{
    "Trade/Device Name(s)": [
        "Multi-Drug Urine Test Cup",
        "Multi-Drug Urine Test Panel",
        "Wondfo Multi-Drug Urine Test Cup",
        "Wondfo Multi-Drug Urine Test Panel"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K130665",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112071"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DKZ",
        "LDJ",
        "DIO",
        "LAF",
        "JXM",
        "LCM",
        "DIS"
    ],
    "Summary Letter Date": "April 9, 2013",
    "Summary Letter Received Date": "March 12, 2013",
    "Submission Date": "March 6, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3170",
        "21 CFR 862.3150"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Amphetamine test system",
        "Cannabinoids test system",
        "Cocaine and cocaine metabolites test system",
        "Methamphetamine test system",
        "Benzodiazepine test system",
        "Barbiturate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Secobarbital",
        "Oxazepam",
        "Cocaine",
        "Cannabinoids",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Morphine 2000",
        "Phencyclidine",
        "Oxycodone",
        "Buprenorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cup",
        "Dip card"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay",
        "Immunoassay"
    ],
    "Methodologies": [
        "Antigen-antibody immunochemistry",
        "Qualitative analysis"
    ],
    "Submission Type(s)": [
        "Panel",
        "Cup",
        "Dip card"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo Multi-Drug Urine Test Cup and Panel, qualitative lateral flow immunoassay for simultaneous detection of multiple drugs of abuse in urine",
    "Indications for Use Summary": "Qualitative and simultaneous detection of Amphetamine, Secobarbital, Oxazepam, Cocaine, Cannabinoids, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Morphine 2000, Phencyclidine, Oxycodone, and Buprenorphine in human urine; provides preliminary results requiring confirmatory testing",
    "fda_folder": "Toxicology"
}